Current treatment for colorectal cancer metastatic to the liver

European Journal of Surgical Oncology

Volumn 25, Issue 5, 1999, Pages 451-463

  Cromheecke, M ^a   De Jong, K P ^a   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Colorectal cancer; Liver metastasis; Treatment

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; MELPHALAN; MITOMYCIN C; OXALIPLATIN;

CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

EID: 0032848967     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0679     Document Type: Review

References (210)

1. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 199:1984;306-316.
2. Kemeny N, Schneider A. Regional treatment of hepatic metastases and hepatocellular carcinoma. Curr Probl Cancer. 13:1989;199-283.
3. Adson MA. Resection of liver metastases - when is it worthwhile? World J Surg. 11:1987;511-520.
4. Daly JM, Kemeny NE. Metastatic cancer to the liver. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology. Philadelphia; Lippincott. 1997;2551-2569.
5. Hughes KS, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver: optimizing the results of treatment. In: Cady B (eds). The Surgical Clinics of North America. Philadelphia; W.B. Saunders. 1989;339-360.
6. Niederhuber JE, Ensminger WF. Treatment of metastatic cancer to the liver. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. Philadelphia; Lippincott. 1993;2201-2225.
7. Hugh TJ, Kinsella AR, Poston GJ. Management strategies for colorectal liver metastases - part I. Surg Oncol. 6:1997;19-30.
8. Nakamura S, Suzuki S, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg. 21:1997;741-747.
9. Bismuth H, Adam R, Navarro F, Castaing D, Engerran L, Abascal A. Re-resection for colorectal liver metastasis. Surg Oncol Clin N Am. 5:1996;353-364.
10. Fong Y, Kemenyu N, Patyu P, Blumgartu LH, Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol. 12:1996;219-252.
11. Nordlinger B, Guiguet M, Vaillant JC. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 77:1996;1254-1262.
12. Foster JH. Survival after liver resection for secondary tumors. Am J Surg. 135:1978;389-394.
13. Cady B, Oberfield RA. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg. 127:1974;220-227.
14. Petrelli NJ, Nambisan RN, Herrer L, Mittelman A. Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg. 149:1985;205-209.
15. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin. 45:1995;50-62.
16. Weiss L, Grundmann E, Torhorst J. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 150:1986;195-203.
17. Jaffe BM, Donegan WL, Watson F. Factors influencing survival in patients with untreated hepatic metatases. Surg Gynecol Obstet. 127:1968;1-11.
18. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 141:1981;586-589.
19. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 2:1976;285-288.
20. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch Surg. 119:1984;647-651.
21. Wagner JS, Adson MA, van Heerden JA. The natural history of hepatic metatases from colorectal cancer. A comparison with resective treatment. Ann Surg. 199:1984;502-508.
22. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg. 111:1976;330-334.
23. Devesa JM, Morales V, Enriquez JM. Colorectal cancer. The bases for a comprehensive follow-up. Dis Colon Rectum. 31:1988;636-652.
24. Ovaska J, Jarvinen H, Kujari H, Perttil I, Mecklin JP. Follow-up of patients operated on for colorectal carcinoma. Am J Surg. 159:1990;593-596.
25. Lautenbach E, Forde KA, Neugut AI. Benefits of colonoscopic surveillance after curative resection of colorectal cancer. Ann Surg. 220:1994;206-211.
26. Tornqvist A, Ekelund G, Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg. 69:1982;725-728.
27. Wanebo HJ. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery. 89:1981;290-295.
28. Ballantyne GH, Modlin IM. Postoperative follow-up for colorectal cancer: who are we kidding? J Clin Gastroenterol. 10:1988;359-364.
29. Hulton NR, Hargreaves AW. Is long-term follow-up of all colorectal cancer necessary? J R Coll Surg Edinb. 34:1989;21-24.
30. Camunas J, Enriquez JM, Devesa JM, Morales V, Millan I. Value of follow-up in the management of recurrent colorectal cancer. Eur J Surg Oncol. 17:1991;530-535.
31. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CY. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 219:1994;174-182.
32. Rosen M, Chan L, Beart RWJ, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 41:1998;1116-1126.
33. Steele GJ. Follow-up plans after treatment of primary colon and rectum cancer. World J Surg. 15:1991;583-588.
34. de Salvo L, Razzetta F, Arezzo A. Surveillance after colorectal cancer surgery. Eur J Surg Oncol. 23:1997;522-525.
35. Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. 58:1986;603-610.
36. Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer. 31A:1995;1207-1209.
37. Bruinvels DJ, de Brauw LM, Kievit J, Habbema JD, van de Velde CY. Attitudes towards detection and management of hepatic metastases of colorectal origin: a second look. HPB Surg. 8:1994;115-122.
38. Kievit J, Bruinvels DJ. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer. 31A:1995;1222-1225.
39. Bruinvels DJ, Stiggelbout AM, Klaassen MP. Follow-up after colorectal cancer: current practice in The Netherlands. Eur J Surg. 161:1995;827-831.
40. Sugarbaker PH. Follow-up of colorectal cancer. Tumori. 81:1995;126-134.
41. Kronborg O. Optimal follow-up in colorectal cancer patients: what tests and how often? Semin Surg Oncol. 10:1994;217-224.
42. Flanagan LJ, Foster JH. Hepatic resection for metastatic cancer. Am J Surg. 113:1967;551-557.
43. Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg. 22:1998;268-276.
44. Hamm B. The value of magnetic resonance tomography in the detection and differential diagnosis of focal liver lesions. Radiologe. 32:1992;232-240.
45. Delbeke D, Vitola JV, Sandler MP. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 38:1997;1196-1201.
46. Longmaid HE, Dupuy DE, Kane RA, Finn JP, Costello P. Noninvasive liver imaging: new techniques and practical strategies. Semin Ultrasound CT MR. 13:1992;377-398.
47. Grellet J, Bellin MF, Dion E, Rosier H, Auberton E. [MRI techniques applied to the diagnosis of hepatic tumors] Techniques d'IRM appliquees au diagnostic des tumeurs hepatiques. J Radiol. 74:1993;67-76.
48. van Ooijen B, Oudkerk M, Schmitz PIM, Wiggers T. Detection of liver metastases from colorectal carcinoma: is there a place for routine computed tomography arteriography? Surgery. 119:1996;511-516.
49. Scheele J. Hepatectomy for liver metastases. Br J Surg. 80:1993;274-276.
50. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: treatment by hepatic resection. Ann Surg. 199:1984;306-316.
51. Adson MA, Heerden JA. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 191:1980;576-583.
52. Hughes KS. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery. 100:1986;278-283.
53. Ooijen B, Wiggers T, Meijer S, Heijde MN, Slooff MJH, van der Velde CJH. Hepatic resections for colorectal metastases in the Netherlands. Cancer. 70:1992;28-34.
54. Koh WJ, Russell KJ, Cain JM. Intraoperative electron beam therapy. Radiol Med (Torino). 80:1990;86-87.
55. Hughes KS, Simon R, Songhorabodi S. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery. 103:1988;278-288.
56. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg. 173:1997;467-471.
57. Isenberg J, Fischbach R, Kruger I, Keller HW. Treatment of liver metastases from colorectal cancer. Anticancer Res. 16:1996;1291-1295.
58. Fegiz G, Ramacciato G, Gennari L. Hepatic resections for colorectal metastases: the Italian multicenter experience. J Surg Oncol (Suppl.). 2:1991;144-154.
59. Fong Y, Cohen AM, Fortner JG. Liver resection for colorectal metastases. J Clin Oncol. 15:1997;938-946.
60. Sugihara K, Hojo K, Moriy Y, Yamasaki S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg. 80:1993;1032-1035.
61. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 132:1997;505-510.
62. Adam R, Bismuth H, Castaing D. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 225:1997;51-60.
63. Chu QD, Vezeridis MP, Avradopoulos KA, Wanebo HJ. Repeat hepatic resection for recurrent colorectal cancer. World J Surg. 21:1997;292-296.
64. Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol. 4:1997;125-130.
65. Bines SD, Doolas A, Jenkins L, Millikan K, Roseman DL. Survival after repeat hepatic resection for recurrent colorectal hepatic metastases. Surgery. 120:1996;591-596.
66. Wanebo HJ, Chu QD, Avradopoulos KA, Vezeridis MP. Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery. 119:1996;361-371.
67. Hughes KS, Rosenstein RB, Songhorabodi S. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum. 31:1988;1-4.
68. Wang JY, Chiang JM, Jeng LB, Changchien CR, Chen JS, Hsu KC. Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? Dis Colon Rectum. 39:1996;847-851.
69. Doci R, Gennari L, Bignami P. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 78:1991;797-801.
70. Seifert JK, Junginger T. Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors. Langenbecks Arch Chir. 381:1996;187-200.
71. D'Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 185:1997;554-559.
72. Jaeck D, Bachellier P, Guiguet M. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg. 84:1997;977-980.
73. Jatzko GR, Lisborg PH, Stettner HM, Klimpfinger MH. Hepatic resection for metastases from colorectal carcinoma - a survival analysis. Eur J Cancer. 31A:1995;41-46.
74. Scheele J, Stangl R, Altendor-Hofman A. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 110:1991;13-29.
75. Eckberg H, Tranberg KG, Andersson R. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg. 11:1987;541-547.
76. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg. 84:1997;1136-1140.
77. Rougier P, Milan C, Lazorthes F. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg. 82:1995;1397-1400.
78. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease - free survival in patients with complete resection of colorectal liver metastases. Ann Surg. 214:1991;107-113.
79. Cady B, Stone MD, McDermott WV, Jr. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg. 127:1992;561-568.
80. Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg. 219:1994;135-143.
81. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol. 16:1990;360-365.
82. Nadigu DE, Wade TP, Fairchild RB, Virgo KS, Johnson FE. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch Surg. 132:1997;115-119.
83. Lise M, Da Pian PP, Nitti D, Pilati PL, Prevaldi C. Colorectal metastases to the liver: present status of management. Dis Colon Rectum. 33:1990;688-694.
84. Ekberg H, Tranberg KG, Andersson R. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 73:1986;727-731.
85. Nakamura S, Yokoi, Suzuki S, Baba S, Mura H. Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg. 79:1992;35-38.
86. Shirabe K, Takenaka K, Gion T. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg. 84:1997;1077-1080.
87. Iwatsuki S, Esquivel CO, Gordon RD. Liver resection for metastatic colorectal cancer. Surgery. 100:1986;804-810.
88. Gouda J, Brown J, Carter D, Dobelbower RR, Jr. Malignant brain tumors treated with IORT. Front Radiat Ther Oncol. 31:1997;87-91.
89. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet. 162:1986;109-113.
90. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg. 205:1987;256-263.
91. Gayowski TJ, Iwatsuki S, Madariaga JR. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors [see comments]. Surgery. 116:1994;703-710.
92. Bakalakos EA, Kim JA, Young DC, Martin EW, Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg. 22:1998;399-404.
93. Cadyu B, Jenkins RL, Steele GD, Jr. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 227:1998;566-571.
94. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 19:1995;59-71.
95. Scheele J. Resection for colorectal metastases. In: European Postgraduate Gastro-surgical school (EPGS). Imaging and Treatment of Hepatic Tumors. Amsterdam, The Netherlands, February 5-6. 1998 (abstract).
96. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg. 63:1997;605-610.
97. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg. 131:1996;322-329.
98. Rosen CB, Nagorney DM, Taswell HF. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 216:1992;493-504.
99. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg. 155:1988;378-382.
100. Beckurts KT, Holscher AH, Thorban S, Bollschweiler E, Siewert JR. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg. 84:1997;1081-1084.
101. VanderMeer TJ, Callery MP, Meyers WC. The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma. Hematol Oncol Clin North Am. 11:1997;759-777.
102. Vigneswaran WT. Management of pulmonary metastases from colorectal cancer. Semin Surg Oncol. 12:1996;264-266.
103. Smith JW, Fortner JG, Burt M. Resection of hepatic and pulmonary metastases from colorectal cancer. Surg Oncol. 1:1992;399-404.
104. de Jong KP, Slooff MJ, de Vries EG, Brouwers MA, Terpstra OT. Effect of partial liver resection on tumour growth. J Hepatol. 25:1996;109-121.
105. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg. 209:1989;428-434.
106. Yamamoto J, Sugihara K, Kosuge T. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg. 221:1995;74-78.
107. Elias D, Cavalcanti A, Sabourin JC. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol. 24:1998;174-179.
108. Leichman CG, Fleming TR, Muggia FM. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study [see comments]. J Clin Oncol. 13:1995;1303-1311.
109. Petrelli NJ, Douglass HO, Herrera L. The modulation of fluouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol. 7:1989;1419-1426.
110. Leichmann CC, Fleming J. Phase II study of fluorouracil and its modulation in advanced colorectal cancer. J Clin Oncol. 13:1995;1303-1311.
111. Ehrlichmann C, Fine S, Wong A. Randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol. 6:1988;469-475.
112. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet. 350:1997;681-686.
113. Hill M, Norman P. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-26 in advanced colorectal cancer. J Clin Oncol. 13:1995;1297-1302.
114. J Clin Oncol. 13:1995;921-928.
115. Adson MA, Heerden van JA, Adson MH. Resection of hepatic metastases from colorectal cancer: major hepatic resection for metachronous metastases from colorectal cancer. Ann Chir. 210:1985;204-209.
116. Hugh TJ, Kinsell AR, Poston GJ. Management strategies for colorectal liver metastases - Part II. Surg Oncol. 6:1997;31-48.
117. Makela J, Kantola R, Tikkakoski T. Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer. J Surg Oncol. 65:1997;127-131.
118. Wagman L, Kemeny MM, Leong L. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 8:1990;1885-1893.
119. Davidson BS, Izzo F, Chase JL. Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg. 172:1996;244-247.
120. Chang AE, Schneider PD, Sugarbaker PH. A prospective randomized trial of regional vs systemic continous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Chir. 206:1987;685-693.
121. Durand-Zaleski I, Roche B, Buyse M. Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst. 89:1997;790-795.
122. Venook AP. Update on hepatic intra-arterial chemotherapy. Oncology Huntingt. 11:1997;947-957.
123. Venook AP, Warren RS. Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Oncol Clin N Am. 5:1996;411-427.
124. Vauthey JN, Marsh RW, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Br J Surg. 83:1996;447-455.
125. Rougier P, Laplanche A, Huguier M. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial [see comments]. J Clin Oncol. 10:1992;1112-1118.
126. Kemeny MM, Goldberg D, Beatty D. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer. 57:1986;492-498.
127. J Natl Cancer Inst. 88:1996;252-258.
128. Marinelli A, de Brauw LM, Beerman H. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. Jpn J Clin Oncol. 26:1996;341-350.
129. O'Connel MJ, Adson MA, Schutt J, Rubin J, Moertel CG, lstrupu DM. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc. 60:1985;517-520.
130. Curley SA, Roh MS, Chase JL. Adjuvant heaptic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg. 166:1993;743-748.
131. Patt YZ. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol. 11:1993;815-819.
132. Bismuth H, Adam R, Levi F. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 224:1996;509-520.
133. Bismuth H, Adam R. Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy. Semin Oncol. 25:1998;40-46.
134. Becouarn Y, Ychou M, Ducreux M. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol. 16:1998;2739-2744.
135. Taylor I. Cytotoxic perfusion for colorectal liver metastases. Br J Surg. 65:1978;109-114.
136. Petrelli NJ, Barcewicz PA, Evans JT, Ledesma EJ, Lawrence DD, Mittelman A. Hepatic artery ligation for liver metastasis in colorectal carcinoma. Cancer. 53:1984;1347-1353.
137. Hunt TM, Flowerdew AD, Birch SJ, Williams JD, Mullee MA, Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases [see comments]. Br J Surg. 77:1990;779-782.
138. Cooper IS. Cryogenic surgery. N Engl J Med. 268:1963;743-749.
139. Morris DL, Ross WB. Australian experience of cryoablation of liver tumors: metastases. Surg Oncol Clin N Am. 5:1996;391-397.
140. Onik G, Rubinsky B, Zemel R. Ultrasound-guided hepatic cryosurgery in the treatment of metatatic colon carcinoma. Cancer. 67:1991;901-907.
141. Ravikumar TS, Steele G, Jr, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 51:1991;6323-6327.
142. Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele GJ. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg. 126:1991;1520-1523.
143. Onik GM, Atkinson D, Zemel R, Weaver ML. Cryosurgery of liver cancer. Semin Surg Oncol. 9:1993;309-317.
144. Onik G, Rubinsky B, Zemel R. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer. 67:1991;901-907.
145. Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg. 225:1997;193-201.
146. Polk W, Fong Y, Karpeh M, Blumgart LH. A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg. 180:1995;171-176.
147. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 225:1997;39-38.
148. Yeh KA, Fortunato L, Hoffman JP, Eisenberg BL. Cryosurgical ablation of hepatic metastases from colorectal carcinomas. Am Surg. 63:1997;63-68.
149. McKinnon JG, Temple WJ, Wiseman DA, Saliken JC. Cryosurgery for malignant tumours of the liver [see comments]. Can J Surg. 39:1996;401-406.
150. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am J Surg. 171:1996;27-31.
151. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer. 76:1995;210-214.
152. Tandan VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. Can J Surg. 40:1997;175-181.
153. Tandan VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. Can J Surg. 40:1997;175-181.
154. Borgelt BB, Gelber R, Brady LW, Griffin T, Hendrickson FR. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys. 7:1981;587-591.
155. Leibel SA, Order SE, Rominger CJ, Asbell SO. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study. Cancer Clin Trials. 4:1981;285-293.
156. Leibel SA, Guse C, Order SE. Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies. Int J Radiat Oncol Biol Phys. 18:1990;523-528.
157. Phillips R, Karnovsky DA, Hamilton LD, Nickson JJ. Roentgen therapy of hepatic metastases. Am J Roentgenol. 71:1954;826-834.
158. Prasad B, Lee MS, Hendrickson FR. Irradiation of hepatic metastases. Int J Radiat Oncology Biol Phys. 2:1977;129-132.
159. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys. 27:1993;117-123.
160. Eble MJ, Gademann G, Wannenmacher M. [The value of radiotherapy for liver metastases] Zur Wertigkeit der Radiotherapie bei Lebermetastasen. Strahlenther Onkol. 169:1993;459-468.
161. Mohiuddin M, Chen E, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol. 14:1996;722-728.
162. Wiley AL, Wirtanen GW, Stephenson JA, Ramirez G, Demets D, Lee JW. Combined hepatic artery 5-fluroouracil and irradiation of liver metastases. Cancer. 64:1989;1738-1789.
163. Raju PI, Maruyama Y, DeSimone P, MacDonald J. Treatment of liver metastases with a combination of chemotherapy and hyperfractionated external radiation therapy. Am J Clin Oncol. 10:1987;41-43.
164. Webber BM, Soderberg CH, Jr, Leone LA, Rege VB, Glicksman AS. A combined treatment approach to management of hepatic metastasis. Cancer. 42:1978;1087-1095.
165. Turek-Maischeider M, Kazem I. Palliative irradiation for liver metastases. JAMA. 232:1975;625-628.
166. Turek M. Radiation therapy of the liver metastatic disease. Radiol Clin (Basel). 44:1975;142-145.
167. Kraut JW. Radiation therapy's role in the management of liver metastases. Int J Radiat Oncol Biol Phys. 1:1976;977-979.
168. Mantyla M, Nordman E. Radiation treatment of liver metastases. Strahlentherapie. 154:1978;182-184.
169. Sherman DM, Weichselbaum R, Order SE, Cloud L, Trey C, Piro AJ. Palliation of hepatic metastasis. Cancer. 41:1978;2013-2017.
170. Armstrong JG, Burman C, Leibel S. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 26:1993;685-689.
171. Gupta MK, Ajayi DO. Dependence of tolerance dose on irradiated volume in radiotherapy, and determination of volume corrected time, dose and fractionation factors. Clin Radiol. 33:1982;615-620.
172. Lawrence TS, Tesser RJ, Ten Haken RK. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys. 19:1990;1041-1047.
173. Lawrence TS, Kessler ML, Robertson JM. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer. Oncology (Huntingt). 7:1993;51-57.
174. Lee CKK, Bloomfield CD, Levitt SH. Liver irradiation in stage III A Hodgkin's disease patients with splenic involvement. Am J Clin Oncol. 7:1984;149-157.
175. Austin-Seymour MM, Chen GT, Castro JR. Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys. 12:1986;31-35.
176. Lawrence TS, Dworzanin LM, Walker-Andrews SC. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys. 20:1991;555-561.
177. Thomas DS, Nauta RJ, Rodgers JE. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer. 71:1993;1977-1981.
178. Dritschilo A, Harter KW, Thomas D. Intraoperative radiation therapy of hepatic metastases: technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys. 14:1988;1007-1011.
179. Nauta RJ, Heres EK, Thomas DS. Intraoperative single-dose radiotherapy. Observations on staging and interstitial treatment of unresectable liver metastases. Arch Surg. 122:1987;1392-1395.
180. Holt RW, Nauta RJ, Lee TC. Intraoperative interstitial radiation therapy for hepatic metastases from colorectal carcinomas. Am Surg. 54:1988;231-233.
181. Dritschilo A, Grant EG, Harter KW, Holt RW, Rustgi SN, Rodgers JE. Interstitial radiation therapy for hepatic metastases: sonographic guidance for applicator placement. Am J Roentgenol. 147:1986;275-278.
182. Holt RW, Nauta RJ, Lee TC. Intraoperative interstitial radiation therapy for hepatic metastases from colorectal carcinomas. Am Surg. 54:1988;231-233.
183. Dritschilo A, Harter KW, Thomas D. Intraoperative radiation therapy of hepatic metastases: technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys. 14:1988;1007-1011.
184. Donath D, Nori D, Turnbull A, Kaufman N, Fortner JG. Brachytherapy in the treatment of solitary colorectal metastases to the liver. J Surg Oncol. 44:1990;55-61.
185. Armstrong JG, Anderson LL, Harrison LB. Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer. 73:1994;1800-1804.
186. Ychou M, Ricard M, Lumbroso J. Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues. Eur J Cancer. 29A:1993;1105-1111.
187. Muller-Gartner HW, Montz R, Klapdor R, Hirschmann M, Rehpenning W, Langkowski J. Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies - initial results of a clinical study. Nuklearmedizin. 27:1988;258-265.
188. Burton MA, Gray BN. Adjuvant internal radiation therapy in a model of colorectal cancer-derived hepatic metastases. Br J Cancer. 71:1995;322-325.
189. Burton MA, Gray BN, Kelleher DK, Klemp PF. Selective internal radiation therapy: validation of intraoperative dosimetry. Radiology. 175:1990;253-255.
190. Gray BN, Anderson JE, Burton MA. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg. 62:1992;105-110.
191. Gray BN, Burton MA, Kelleher D, Klemp P, Matz L. Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys. 18:1990;619-623.
192. Hafstrom LR, Holmberg SB, Naredi PL. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol. 3:1994;103-108.
193. Fraker DL, Alexander H. Isolated perfusion of the liver. In: Lotze MT, Rubin JT (eds). Regional Therapy of Advanced Cancers. Philadelphia; Lippincott-Raven. 1997;141-150.
194. Nagata Y, Hiraoka M, Nishimura Y. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys. 38:1997;359-365.
195. Elias D, Debaere T, Muttillo I, Cavalcanti A, Coyle C, Roche A. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol. 67:1998;190-191.
196. Patterson EJ, Scudamore CH, Buczkowski AK, Owen DA, Nagy AG. Radiofrequency ablation in surgery. In: Szabo Z, Lewis JE, Fantini GA, Savalgi RS (eds). Surgical technology International VI. Hong Kong; Universal Medical Press, Inc. 1997;69-75.
197. Solbiati L, Ierace T, Goldberg SN. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 202:1997;195-203.
198. van Hillegersberg R, Kort WJ, Vermeij M, Terpstra OT. Treatment of experimental liver metastases with a noncontact neodymium: YAG laser. J Surg Res. 53:1992;128-135.
199. Nolsoe CP, Torp-Pedersen S, Burcharth F. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology. 187:1993;333-337.
200. Amin Z, Donald JJ, Masters A. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology. 187:1993;339-347.
201. Vogl TJ, Mack MG, Roggan A. Internally cooled power laser for MR-guided
202. Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhuas P. Therapiemoglichkeiten bei nicht resektabelen; Lebermetastasen. Chirurg. 70:1999;133-140.
203. Vogl TJ, Mack MG, Straub R, Roggan A, Felix R. Magnetic resonance imaging - guided abdominal interventional radiology: laser-induced thermotherapy of liver metastases. Endoscopy. 29:1997;577-583.
204. Welt S, Divgi CR, Kemeny N. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol. 12:1994;1561-1571.
205. Welt S, Divgi CR, Scott AM. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol. 12:1994;1193-1203.
206. Elias D, Farace F, Triebel F. Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum. J Am Coll Surg. 181:1995;303-310.
207. Schlag PM, Milleck J, Liebrich W. Active specific immunotherapy in hepatic metastasis. Ann Ital Chir. 67:1996;783-791.
208. Qin Y, Van Cauteren M, Osteaux M, Schally AV, Willems G. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging. Cancer Res. 52:1992;6025-6030.
209. Konno H, Tanaka T, Matsuda I. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. Int J Cancer. 61:1995;268-271.
210. Geraghty PJ, Chang AE. Basic principles associated with gene therapy of cancer. Surg Oncol. 4:1995;125-137.